Milestones, announcements, and perspectives on the science of single-cell diagnostics.
How combining optical sensing with machine learning turns raw cellular signals into actionable insight.
Developing screening tests is expensive and infeasible for many diseases. Lowering that cost could change outcomes.
A new deep-tech company is building an optical + AI platform to detect disease at the level of the individual cell.
